• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自软毛南酸枣 Garcinia nervosa var. pubescens King 的新双黄酮具有血小板激活因子 (PAF)拮抗活性。

Platelet-activating factor (PAF) antagonistic activity of a new biflavonoid from Garcinia nervosa var. pubescens King.

机构信息

Drug and Herbal Research Centre, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, 50300 Kuala Lumpur, Malaysia.

出版信息

Molecules. 2012 Sep 10;17(9):10893-901. doi: 10.3390/molecules170910893.

DOI:10.3390/molecules170910893
PMID:22964504
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6268030/
Abstract

The methanol extract of the leaves of Garcinia nervosa var. pubescens King, which showed strong inhibitory effects on platelet-activating factor (PAF) receptor binding, was subjected to bioassay-guided isolation to obtain a new biflavonoid, II-3,I-5, II-5,II-7,I-4',II-4'-hexahydroxy-(I-3,II-8)-flavonylflavanonol together with two known flavonoids, 6-methyl-4'-methoxyflavone and acacetin. The structures of the compounds were elucidated by spectroscopic methods. The compounds were evaluated for their ability to inhibit PAF receptor binding to rabbit platelets using ³H-PAF as a ligand. The biflavonoid and acacetin showed strong inhibition with IC₅₀ values of 28.0 and 20.4 µM, respectively. The results suggest that these compounds could be responsible for the strong PAF antagonistic activity of the plant.

摘要

杨桃科藤山柳属植物显齿蛇葡萄叶甲醇提取物对血小板活化因子(PAF)受体具有较强的抑制作用,采用生物活性跟踪分离方法,从中分离得到一个新的二氢黄酮醇,即 II-3,I-5, II-5,II-7,I-4',II-4'-六羟基(I-3,II-8)-二氢黄酮基二氢黄酮醇,同时还分离得到两个已知的黄酮类化合物,即 6-甲基-4'-甲氧基黄酮和芹菜素。通过波谱方法解析了这些化合物的结构。采用 ³H-PAF 作为配体,评价了这些化合物对兔血小板 PAF 受体结合的抑制能力。该二氢黄酮醇和芹菜素的抑制活性较强,IC₅₀ 值分别为 28.0 和 20.4 μM。结果表明,这些化合物可能是该植物具有较强的 PAF 拮抗活性的原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccd5/6268030/9fe41290f84c/molecules-17-10893-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccd5/6268030/f02fef389633/molecules-17-10893-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccd5/6268030/9fe41290f84c/molecules-17-10893-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccd5/6268030/f02fef389633/molecules-17-10893-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccd5/6268030/9fe41290f84c/molecules-17-10893-g002.jpg

相似文献

1
Platelet-activating factor (PAF) antagonistic activity of a new biflavonoid from Garcinia nervosa var. pubescens King.来自软毛南酸枣 Garcinia nervosa var. pubescens King 的新双黄酮具有血小板激活因子 (PAF)拮抗活性。
Molecules. 2012 Sep 10;17(9):10893-901. doi: 10.3390/molecules170910893.
2
Platelet-activating factor (PAF) receptor binding activity of the roots of Enicosanthellum pulchrum.美丽肾蕨根的血小板激活因子(PAF)受体结合活性。
Pharm Biol. 2012 Mar;50(3):284-90. doi: 10.3109/13880209.2011.602416. Epub 2011 Nov 21.
3
Inhibitory effect of compounds from Goniothalamus tapis Miq. and Goniothalamus uvaroides King on platelet-activating factor receptor binding.从瓜馥木和瓜叶乌头中分离得到的化合物对血小板激活因子受体结合的抑制作用。
Phytother Res. 2012 May;26(5):687-91. doi: 10.1002/ptr.3620. Epub 2011 Oct 17.
4
Platelet-activating factor (PAF) receptor binding antagonist activity of the methanol extracts and isolated flavonoids from Chromolaena odorata (L.) King and Robinson.飞机草(Chromolaena odorata (L.) King and Robinson)甲醇提取物及分离出的黄酮类化合物的血小板活化因子(PAF)受体结合拮抗活性。
Biol Pharm Bull. 2007 Jun;30(6):1150-2. doi: 10.1248/bpb.30.1150.
5
Antiplatelet aggregation and platelet activating factor (PAF) receptor antagonistic activities of the essential oils of five Goniothalamus species.五种柿科柿属植物精油的抗血小板聚集和血小板激活因子(PAF)受体拮抗活性。
Molecules. 2010 Jul 29;15(8):5124-38. doi: 10.3390/molecules15085124.
6
Inhibitory effects of acetylmelodorinol, chrysin and polycarpol from Mitrella kentii on prostaglandin E₂ and Thromboxane B₂ production and platelet activating factor receptor binding.从 Mitrella kentii 中提取的乙酰基麦角硫因、白杨黄素和多卡醇对前列腺素 E₂ 和血栓烷 B₂ 产生及血小板激活因子受体结合的抑制作用。
Molecules. 2012 Apr 26;17(5):4824-35. doi: 10.3390/molecules17054824.
7
In vitro inhibitory effect of rubraxanthone isolated from Garcinia parvifolia on platelet-activating factor receptor binding.从小叶藤黄中分离得到的红厚壳素对血小板活化因子受体结合的体外抑制作用。
Planta Med. 2002 Dec;68(12):1133-4. doi: 10.1055/s-2002-36343.
8
Platelet-activating factor (PAF) receptor-binding antagonist activity of Malaysian medicinal plants.马来西亚药用植物的血小板活化因子(PAF)受体结合拮抗剂活性。
Phytomedicine. 2005 Jan;12(1-2):88-92. doi: 10.1016/j.phymed.2003.06.006.
9
Alpha-bulnesene, a novel PAF receptor antagonist isolated from Pogostemon cablin.α-布藜烯,一种从广藿香中分离出的新型血小板活化因子受体拮抗剂。
Biochem Biophys Res Commun. 2006 Jul 7;345(3):1033-8. doi: 10.1016/j.bbrc.2006.05.006. Epub 2006 May 8.
10
[Inhibitory effect of kaempferol against binding of platelet activating factor to its receptor].山柰酚对血小板活化因子与其受体结合的抑制作用
Zhongguo Zhong Yao Za Zhi. 2004 Aug;29(8):789-91.

引用本文的文献

1
Phytochemical profile and diverse pharmacology of L.L.的植物化学特征与多种药理学特性
Heliyon. 2024 May 3;10(9):e30629. doi: 10.1016/j.heliyon.2024.e30629. eCollection 2024 May 15.
2
Coagulation System Activation for Targeting of COVID-19: Insights into Anticoagulants, Vaccine-Loaded Nanoparticles, and Hypercoagulability in COVID-19 Vaccines.针对 COVID-19 的凝血系统激活:抗凝剂、疫苗负载纳米颗粒以及 COVID-19 疫苗中高凝状态的见解。
Viruses. 2022 Jan 24;14(2):228. doi: 10.3390/v14020228.
3
Proceedings of Chemistry, Pharmacology, Pharmacokinetics and Synthesis of Biflavonoids.

本文引用的文献

1
Inhibitory effects of phylligenin and quebrachitol isolated from Mitrephora vulpina on platelet activating factor receptor binding and platelet aggregation.从黄杨叶九里香中分离得到的 Phylligenin 和奎那醇对血小板激活因子受体结合和血小板聚集的抑制作用。
Molecules. 2010 Nov 3;15(11):7840-8. doi: 10.3390/molecules15117840.
2
Role of platelet-activating factor in cell death signaling in the cornea: A review.血小板激活因子在角膜细胞死亡信号中的作用:综述。
Mol Neurobiol. 2010 Aug;42(1):32-8. doi: 10.1007/s12035-010-8129-1. Epub 2010 Apr 30.
3
Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes.
双黄酮类化合物的化学、药理学、药代动力学和合成研究进展。
Molecules. 2021 Oct 8;26(19):6088. doi: 10.3390/molecules26196088.
4
Natural Products for Antithrombosis.用于抗血栓形成的天然产物。
Evid Based Complement Alternat Med. 2015;2015:876426. doi: 10.1155/2015/876426. Epub 2015 May 17.
血小板活化因子,一种生理和病理过程的多效性介质。
Crit Rev Clin Lab Sci. 2003 Dec;40(6):643-72. doi: 10.1080/714037693.
4
Effect of buyang huanwu decoction on platelet activating factor content in arterial blood pre- and post-arterial thrombosis in rats.补阳还五汤对大鼠动脉血栓形成前后动脉血中血小板活化因子含量的影响。
J Tradit Chin Med. 2001 Dec;21(4):299-302.
5
The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis.炎症与血栓形成综合征中的血小板活化因子信号系统及其调节因子
Crit Care Med. 2002 May;30(5 Suppl):S294-301. doi: 10.1097/00003246-200205001-00020.
6
Platelet-activating factor induces histamine release from human skin mast cells in vivo, which is reduced by local nerve blockade.血小板活化因子可在体内诱导人皮肤肥大细胞释放组胺,局部神经阻滞可减少这种释放。
J Allergy Clin Immunol. 1997 May;99(5):640-7. doi: 10.1016/s0091-6749(97)70026-5.
7
Role of a guanine nucleotide regulatory protein in the activation of phospholipase C by different chemoattractants.鸟嘌呤核苷酸调节蛋白在不同趋化因子激活磷脂酶C中的作用。
J Immunol. 1987 Jun 15;138(12):4374-80.
8
Synthesis and release of platelet-activating factor is inhibited by plasma alpha 1-proteinase inhibitor or alpha 1-antichymotrypsin and is stimulated by proteinases.血小板活化因子的合成与释放受到血浆α1-蛋白酶抑制剂或α1-抗糜蛋白酶的抑制,并受到蛋白酶的刺激。
J Exp Med. 1988 Oct 1;168(4):1293-306. doi: 10.1084/jem.168.4.1293.
9
Role of endothelial leukocyte adhesion molecule-1 and platelet-activating factor in neutrophil adherence to IL-1-prestimulated endothelial cells. Endothelial leukocyte adhesion molecule-1-mediated CD18 activation.内皮细胞白细胞黏附分子-1和血小板活化因子在中性粒细胞黏附于白细胞介素-1预刺激的内皮细胞中的作用。内皮细胞白细胞黏附分子-1介导的CD18活化。
J Immunol. 1991 Aug 15;147(4):1369-76.
10
Endothelial cell interactions with granulocytes: tethering and signaling molecules.内皮细胞与粒细胞的相互作用:拴系和信号分子
Immunol Today. 1992 Mar;13(3):93-100. doi: 10.1016/0167-5699(92)90149-2.